banner
Dofetilide, Purity ≥98%
Inquiry

Cat. No.: X24-09-YM974

Dofetilide, Purity ≥98%

Synonym: 115256-11-6; UK68798; Tikosyn; Dofetilida; Dofetilidum; N-[4-[2-[2-[4-(Methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamide

  • MDL: MFCD00869707
  • CAS Number: 115256-11-6
  • Compound CID: 71329
img
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Dofetilide, soluble in DMSO and insoluble in water and ethanol, is a class III antiarrhythmic agent. The molecular weight of the compound is 441.56, and its molecular formula is C19H27N3O5S2.
Molecular Weight
441.56
Molecular Formula
C19H27N3O5S2
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Solubility
In vitro: DMSO (warmed): 82 mg/mL (185.7 mM); Water: insoluble; Ethanol: insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
Dofetilide can be studied extensively for its potential therapeutic applications in the treatment of atrial fibrillation and atrial flutter.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0